This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4lp0
From Proteopedia
| Line 4: | Line 4: | ||
==About this Structure== | ==About this Structure== | ||
| - | [[4lp0]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LP0 OCA]. | + | [[4lp0]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Strr6 Strr6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LP0 OCA]. |
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:024098982</ref><references group="xtra"/><references/> | <ref group="xtra">PMID:024098982</ref><references group="xtra"/><references/> | ||
| + | [[Category: Strr6]] | ||
[[Category: Basarab, G S.]] | [[Category: Basarab, G S.]] | ||
[[Category: Bist, S.]] | [[Category: Bist, S.]] | ||
Revision as of 06:54, 15 January 2014
Crystal structure of a topoisomerase ATP inhibitor
Template:ABSTRACT PUBMED 24098982
About this Structure
4lp0 is a 1 chain structure with sequence from Strr6. Full crystallographic information is available from OCA.
Reference
- Basarab GS, Manchester JI, Bist S, Boriack-Sjodin PA, Dangel B, Illingworth R, Sherer BA, Sriram S, Uria-Nickelsen M, Eakin AE. Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents. J Med Chem. 2013 Oct 29. PMID:24098982 doi:http://dx.doi.org/10.1021/jm401208b
Categories: Strr6 | Basarab, G S. | Bist, S. | Boriack-Sjodin, P A. | Dangel, B. | Eakin, A E. | Illingsworth, R. | Manchester, J I. | Sherer, B A. | Sriram, S. | Uria-Nickelsen, M. | Antimicrobial | Atp binding | Atpase domain | Isomerase-isomerase inhibitor complex | Protein-inhibitor complex | Structure-based drug design | Virtual screen
